Tag: metastatic clear cell carcinoma

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

byDaniel Goldshteinand1 others

September 9, 2024

1. Median PFS (5.6 months vs 5.6 months) and median OS (21.4 months vs 18.1 months) were similar in both ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Video mental health care may have clinical advantages versus phone or in-person visits
Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair

No Result

View All Result

Tag: metastatic clear cell carcinoma

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits